Series: Cancer Drug Discovery and Development

Hypoxia and Cancer

Role of Autophagy and Reactive Oxygen Species in Cancer Treatment

Tumor Dormancy and Recurrence

BRAF Targets in Melanoma

Role of Autophagy and Reactive Oxygen Species in Cancer Treatment

Nuclear Signaling Pathways and Targeting Transcription in Cancer

Molecular Precision Medicine in Cancer

Role of Gut Microbiota and Postbiotics for Colorectal Cancer

Hypoxia and Cancer

Receptor Tyrosine Kinases in Cancer

Tumor Organoids

Pi3k-mtor in Cancer and Cancer Therapy

Targeting the DNA Damage Response for Anti-Cancer Therapy

Developments in T Cell Based Cancer Immunotherapies

PARP Inhibitors for Cancer Therapy

Gene and Cellular Immunotherapy for Cancer

Targeting the DNA Damage Response for Anti-Cancer Therapy

Tumor Metabolome Targeting and Drug Development

Nitric Oxide (NO) and Cancer

Molecular Targeted Radiosensitizers

Innovations for Next-Generation Antibody-Drug Conjugates

Innovations for Next-Generation Antibody-Drug Conjugates

DNA and Histone Methylation as Cancer Targets

Liquid Biopsies in Solid Tumors

Gene and Cellular Immunotherapy for Cancer

DNA and Histone Methylation as Cancer Targets

Platinum-Based Drugs in Cancer Therapy

Increasing the Therapeutic Ratio of Radiotherapy

Tumor Organoids

Estrogen Receptor and Breast Cancer

Antiangiogenic Agents in Cancer Therapy

STAT Inhibitors in Cancer

Ex Vivo Engineering of the Tumor Microenvironment

Tumor Targeting in Cancer Therapy

Molecular Targeted Radiosensitizers

Tumor Metabolome Targeting and Drug Development